Abstract

Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.
OriginalsprogEngelsk
TidsskriftCochrane Database of Systematic Reviews
Vol/bind2
Sider (fra-til)CD003047
ISSN1469-493X
DOI
StatusUdgivet - 10 feb. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dopamine agents for hepatic encephalopathy'. Sammen danner de et unikt fingeraftryk.

Citationsformater